NYSE$MAX

MediaAlpha Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Announced first quarter 2024 financial results, exceeding expectations across key financial metrics driven by robust growth in the Property & Casualty vertical.

MediaAlpha reported a 13% increase in revenue year-over-year, reaching $126.6 million in Q1 2024. The company experienced a net loss of $(1.5) million, an improvement from $(14.6) million in the first quarter of 2023. Adjusted EBITDA increased to $14.4 million, compared to $7.3 million in the same period last year.

  • Revenue of $126.6 million, up 13% year over year.
  • Transaction Value of $219.1 million, up 13% year over year.
  • Transaction Value from Property & Casualty up 15% year over year to $135 million.
  • Transaction Value from Health up 16% year over year to $69 million.

Headline financials

Total Revenue

$127M

Previous: $112M+13.5%
EPS

-$0.02

Previous: -$0.23+91.3%
Transaction Value

$219M

Previous: $193M+13.4%
P&C Transaction Value

$135M

No prior period
Health Transaction Value

$69.1M

No prior period
Life Transaction Value

$10.2M

No prior period
Other Transaction Value

$4.29M

No prior period
Gross Margin

18.7%

Previous: 16.5%+13.3%
Contribution Margin

21.9%

Previous: 19.2%+14.1%
Adjusted EBITDA

$14.4M

Previous: $7.26M+98.5%
Capital Expenditures

-$34K

No prior period
Free Cash Flow

-$1.11M

Previous: -$10.3M+89.2%
Net Income

-$1.11M

Previous: -$10.3M+89.2%
Operating Income

$2.37M

Previous: -$9.55M+124.8%
Gross Profit

$23.7M

Previous: $18.4M+28.9%
Cash & Equivalents

$14.5M

Previous: $19.5M-25.9%
Total Assets

$153M

Previous: $153M-0.3%
R&D Expense

$4.36M

No prior period
Stock-Based Comp

$8.63M

Previous: $14.3M-39.8%

Revenue & EPS history

MediaAlpha · Revenue · Quarterly

$127M

Q1 2024+13.5%vs Q1 2023
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Forward guidance

MediaAlpha expects a continuation of recent trends in customer acquisition spending in the P&C vertical and anticipates growth in the Health vertical. The company provides guidance for Q2 2024.

Tailwinds

  • Transaction Value between $285 million - $300 million, representing a 132% year-over-year increase at the midpoint of the guidance range.
  • Revenue between $145 million - $155 million, representing a 77% year-over-year increase at the midpoint of the guidance range.
  • Adjusted EBITDA between $15.5 million and $17.5 million, representing a 359% year-over-year increase at the midpoint of the guidance range.
  • Transaction Value in P&C insurance vertical to be 60% to 70% higher than Q1 2024 levels.
  • Transaction Value in Health vertical to grow at a high single to low double-digit rate year over year.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+3.4%

Avg return

Earnings day

+1.5%

Avg return

5 days after

+0.5%

Avg return

30 days after

50%

11 / 22 earnings

Positive

+31.8%

Q3 2022

Best reaction

-18.5%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.1%-11.3%-11.8%
Q4 2025+12.3%+27.9%+23.4%
Q3 2025+10.8%+20.1%+14.7%
Q1 2025+14.2%+18.2%+21.4%
Q4 2024-18.5%-18.6%-11.0%
Q3 2024-12.6%-17.9%-35.5%
Q2 2024+15.0%+12.1%+23.4%
Q1 2024+9.0%+9.3%-12.2%
Q4 2023+22.3%+24.2%+26.0%
Q3 2023-4.6%-15.8%+0.1%
Q2 2023-3.0%-6.2%-13.2%
Q1 2023-2.4%-6.4%+50.7%
Q4 2022+12.3%+4.8%+1.0%
Q3 2022+31.8%+26.4%+2.3%
Q2 2022-15.0%-32.8%-28.9%
Q1 2022-9.6%-22.0%-31.2%
Q4 2021+28.9%+31.6%+39.1%
Q3 2021-1.5%+12.7%-2.1%
Q2 2021-6.6%-19.1%-25.2%
Q1 2021-13.1%-4.2%+3.6%
Q4 2020+3.3%+8.2%-30.3%
Q3 2020+1.8%-7.4%+7.2%
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro